Table 1 Characteristics of the surgery group.
Characteristics | Synchronous double cancers (%) | Isolated esophageal cancers (%) | Isolated gastric cancers (%) | |
|---|---|---|---|---|
Esophageal cancers | Gastric cancers | |||
Age (median, range) | 63 45–71 | 57 33–77 | 55 36–78 | |
Male | 21(80.8%) | 139(73.7%) | 31(60.8%) | |
Female | 5(19.2%) | 47(26.3%) | 20(39.2%) | |
Location | ||||
Upper third | 2 (7.4%) | 24 (92.3%) | 21 (11.3%) | 2 (3.9%) |
Middle third | 13 (50.0%) | 2 (7.7%) | 144 (77.4%) | 12 (23.5%) |
Lower third | 11 (42.6%) | 0 (0%) | 21 (11.3%) | 37 (72.6%) |
Depth of invasion | ||||
T1–2 | 8 (30.8%) | 10 (38.5%) | 41 (22.0%) | 14 (27.4%) |
T3–4 | 18 (69.2%) | 16 (61.5%) | 145 (78.0%) | 37 (72.6%) |
Lymph node metastasis | ||||
Negative | 11 (42.3%) | 9 (34.6%) | 87 (46.8%) | 14 (27.4%) |
Positive | 15 (57.7%) | 17 (65.4%) | 99 (53.2%) | 37 (72.6%) |
Grade | ||||
I | 3 (9.6%) | 4 (15.4%) | 49 (26.3%) | 2 (3.9%) |
II | 14 (53.8%) | 9 (36.6%) | 120 (64.5%) | 10 (19.6%) |
III | 9 (36.6%) | 13 (48.0%) | 17 (9.2%) | 39 (76.5%) |
Total | 26 | 186 | 51 | |
